Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trial
Dimitrios Chantzichristos, Per-Arne Svensson, Terence Garner, Camilla Am Glad, Brian R Walker, Ragnhildur Bergthorsdottir, Oskar Ragnarsson, Penelope Trimpou, Roland H Stimson, Stina W Borresen, Ulla Feldt-Rasmussen, Per-Anders Jansson, Stanko Skrtic, Adam Stevens, Gudmundur Johannsson, Dimitrios Chantzichristos, Per-Arne Svensson, Terence Garner, Camilla Am Glad, Brian R Walker, Ragnhildur Bergthorsdottir, Oskar Ragnarsson, Penelope Trimpou, Roland H Stimson, Stina W Borresen, Ulla Feldt-Rasmussen, Per-Anders Jansson, Stanko Skrtic, Adam Stevens, Gudmundur Johannsson
Abstract
Background: Glucocorticoids are among the most commonly prescribed drugs, but there is no biomarker that can quantify their action. The aim of the study was to identify and validate circulating biomarkers of glucocorticoid action.
Methods: In a randomized, crossover, single-blind, discovery study, 10 subjects with primary adrenal insufficiency (and no other endocrinopathies) were admitted at the in-patient clinic and studied during physiological glucocorticoid exposure and withdrawal. A randomization plan before the first intervention was used. Besides mild physical and/or mental fatigue and salt craving, no serious adverse events were observed. The transcriptome in peripheral blood mononuclear cells and adipose tissue, plasma miRNAomic, and serum metabolomics were compared between the interventions using integrated multi-omic analysis.
Results: We identified a transcriptomic profile derived from two tissues and a multi-omic cluster, both predictive of glucocorticoid exposure. A microRNA (miR-122-5p) that was correlated with genes and metabolites regulated by glucocorticoid exposure was identified (p=0.009) and replicated in independent studies with varying glucocorticoid exposure (0.01 ≤ p≤0.05).
Conclusions: We have generated results that construct the basis for successful discovery of biomarker(s) to measure effects of glucocorticoids, allowing strategies to individualize and optimize glucocorticoid therapy, and shedding light on disease etiology related to unphysiological glucocorticoid exposure, such as in cardiovascular disease and obesity.
Funding: The Swedish Research Council (Grant 2015-02561 and 2019-01112); The Swedish federal government under the LUA/ALF agreement (Grant ALFGBG-719531); The Swedish Endocrinology Association; The Gothenburg Medical Society; Wellcome Trust; The Medical Research Council, UK; The Chief Scientist Office, UK; The Eva Madura's Foundation; The Research Foundation of Copenhagen University Hospital; and The Danish Rheumatism Association.
Clinical trial number: NCT02152553.
Keywords: biomarkers; computational biology; gene expression; glucocorticoids; human; medicine; metabolites; microRNA; multi-omics; systems biology.
Conflict of interest statement
DC DC has received lecture fees from Otsuka, Sanofi, and Shire. PS, TG, CG, RB, RS, SB, UF, PJ, SS No competing interests declared, BW BW is a consultant with Actinogen Medical, inventor on patents owned by the University of Edinburgh relating to HSD1 inhibitors and to the discovery of glucocorticoid-sensitive biomarkers (the HSD1 inhibitor patents have been licensed to Actinogen Medical, patent numbers: WO 2011/135276, WO 2011/033255, and WO 2009/112845); BW is Non-Executive Director of Roslin Technologies Ltd. OR OR has received lecture fees from Novo Nordisk, Ipsen, Sandoz, and Pfizer, an unrestricted research grant from HRA Pharma, and consultancy fees from Novartis and HRA Pharma. PT PT has received lecture fees from Novartis and Novo-Nordisk. AS AS has received lecture fees from Merck. GJ GJ has served as a consultant for Novo Nordisk, Shire, and Astra Zeneca and has received lecture fees from Eli Lilly, Ipsen, Novartis, Novo Nordisk, Merck Serono, Otsuka, and Pfizer.
© 2021, Chantzichristos et al.
Figures
References
- Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005. doi: 10.7554/eLife.05005.
- Ahsan S, Drăghici S. Identifying significantly impacted pathways and putative mechanisms with iPathwayGuide. Current Protocols in Bioinformatics. 2017;57:7.15.1–7.15.7. doi: 10.1002/cpbi.24.
- Alisi A, Da Sacco L, Bruscalupi G, Piemonte F, Panera N, De Vito R, Leoni S, Bottazzo GF, Masotti A, Nobili V. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Laboratory Investigation. 2011;91:283–293. doi: 10.1038/labinvest.2010.166.
- Alwashih MA, Stimson RH, Andrew R, Walker BR, Watson DG. Acute interaction between hydrocortisone and insulin alters the plasma metabolome in humans. Scientific Reports. 2017a;7:11488. doi: 10.1038/s41598-017-10200-9.
- Alwashih MA, Watson DG, Andrew R, Stimson RH, Alossaimi M, Blackburn G, Walker BR. Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia. Scientific Reports. 2017b;7:17092. doi: 10.1038/s41598-017-17220-5.
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. doi: 10.1016/s0092-8674(04)00045-5.
- Battiston F, Cencetti G, Iacopini I, Latora V, Lucas M, Patania A, Young J-G, Petri G. Networks beyond pairwise interactions: structure and dynamics. Physics Reports. 2020;874:1–92. doi: 10.1016/j.physrep.2020.05.004.
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B. 1995;57:289–300. doi: 10.2307/2346101.
- Bergthorsdottir R, Ragnarsson O, Skrtic S, Glad CAM, Nilsson S, Ross IL, Leonsson-Zachrisson M, Johannsson G. Visceral fat and novel biomarkers of cardiovascular disease in patients with Addison's Disease: A Case-Control Study. The Journal of Clinical Endocrinology & Metabolism. 2017;102:4264–4272. doi: 10.1210/jc.2017-01324.
- Björnsdottir S, Sääf M, Bensing S, Kämpe O, Michaëlsson K, Ludvigsson JF. Risk of hip fracture in Addison's disease: a population-based cohort study. Journal of Internal Medicine. 2011;270:187–195. doi: 10.1111/j.1365-2796.2011.02352.x.
- Bordag N, Klie S, Jürchott K, Vierheller J, Schiewe H, Albrecht V, Tonn JC, Schwartz C, Schichor C, Selbig J. Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Scientific Reports. 2015;5:15954. doi: 10.1038/srep15954.
- Borresen SW, Klose M, Baslund B, Rasmussen ÅK, Hilsted L, Friis-Hansen L, Locht H, Hansen A, Hetland ML, Lydolph MC, Feldt-Rasmussen U. Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis. European Journal of Endocrinology. 2017;177:287–295. doi: 10.1530/EJE-17-0251.
- Breiman L. Random forests. Machine Learning. 2001;45:5–32. doi: 10.1023/A:1010933404324.
- Butte AJ, Tamayo P, Slonim D, Golub TR, Kohane IS. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. PNAS. 2000;97:12182–12186. doi: 10.1073/pnas.220392197.
- Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nature Reviews Immunology. 2017;17:233–247. doi: 10.1038/nri.2017.1.
- Carlet M, Janjetovic K, Rainer J, Schmidt S, Panzer-Grümayer R, Mann G, Prelog M, Meister B, Ploner C, Kofler R. Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells. BMC Cancer. 2010;10:638. doi: 10.1186/1471-2407-10-638.
- Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642–655. doi: 10.1016/j.cell.2009.01.035.
- Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26:2363–2367. doi: 10.1093/bioinformatics/btq431.
- Casper J, Zweig AS, Villarreal C, Tyner C, Speir ML, Rosenbloom KR, Raney BJ, Lee CM, Lee BT, Karolchik D, Hinrichs AS, Haeussler M, Guruvadoo L, Navarro Gonzalez J, Gibson D, Fiddes IT, Eisenhart C, Diekhans M, Clawson H, Barber GP, Armstrong J, Haussler D, Kuhn RM, Kent WJ. The UCSC genome browser database: 2018 update. Nucleic Acids Research. 2018;46:D762–D769. doi: 10.1093/nar/gkx1020.
- Chang X, Xu T, Li Y, Wang K. Dynamic modular architecture of protein-protein interaction networks beyond the dichotomy of 'date' and 'party' hubs. Scientific Reports. 2013;3:1691. doi: 10.1038/srep01691.
- Chatr-Aryamontri A, Breitkreutz BJ, Oughtred R, Boucher L, Heinicke S, Chen D, Stark C, Breitkreutz A, Kolas N, O'Donnell L, Reguly T, Nixon J, Ramage L, Winter A, Sellam A, Chang C, Hirschman J, Theesfeld C, Rust J, Livstone MS, Dolinski K, Tyers M. The BioGRID interaction database: 2015 update. Nucleic Acids Research. 2015;43:D470–D478. doi: 10.1093/nar/gku1204.
- Cheng C, Andrews E, Yan KK, Ung M, Wang D, Gerstein M. An approach for determining and measuring network hierarchy applied to comparing the phosphorylome and the regulome. Genome Biology. 2015;16:63. doi: 10.1186/s13059-015-0624-2.
- Chong J, Xia J. MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data. Bioinformatics. 2018;34:4313–4314. doi: 10.1093/bioinformatics/bty528.
- Clayton SA, Jones SW, Kurowska-Stolarska M, Clark AR. The role of microRNAs in glucocorticoid action. Journal of Biological Chemistry. 2018;293:1865–1874. doi: 10.1074/jbc.R117.000366.
- Cleary B, Cong L, Cheung A, Lander ES, Regev A. Efficient generation of transcriptomic profiles by random composite measurements. Cell. 2017;171:1424–1436. doi: 10.1016/j.cell.2017.10.023.
- Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver Cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 2009;28:3526–3536. doi: 10.1038/onc.2009.211.
- Dahlin A, Sordillo JE, McGeachie M, Kelly RS, Tantisira KG, Lutz SM, Lasky-Su J, Wu AC. Genome-wide interaction study reveals age-dependent determinants of responsiveness to inhaled corticosteroids in individuals with asthma. PLOS ONE. 2020;15:e0229241. doi: 10.1371/journal.pone.0229241.
- Davis CA, Hitz BC, Sloan CA, Chan ET, Davidson JM, Gabdank I, Hilton JA, Jain K, Baymuradov UK, Narayanan AK, Onate KC, Graham K, Miyasato SR, Dreszer TR, Strattan JS, Jolanki O, Tanaka FY, Cherry JM. The encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Research. 2018;46:D794–D801. doi: 10.1093/nar/gkx1081.
- Dogan T, Gnad F, Chan J, Phu L, Young A, Chen MJ, Doll S, Stokes MP, Belvin M, Friedman LS, Kirkpatrick DS, Hoeflich KP, Hatzivassiliou G. Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle. Journal of Biological Chemistry. 2017;292:14311–14324. doi: 10.1074/jbc.M117.792754.
- Dong L, Hou X, Liu F, Tao H, Zhang Y, Zhao H, Song G. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells. Cell Biology International. 2019;43:553–564. doi: 10.1002/cbin.11129.
- Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study. BMJ. 2012;345:e4928. doi: 10.1136/bmj.e4928.
- Gan EH, MacArthur K, Mitchell AL, Hughes BA, Perros P, Ball SG, James RA, Quinton R, Chen S, Furmaniak J, Arlt W, Pearce SH. Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment. The Journal of Clinical Endocrinology & Metabolism. 2014;99:111–118. doi: 10.1210/jc.2013-2449.
- GTEx Consortium The Genotype-Tissue expression (GTEx) project. Nature Genetics. 2013;45:580–585. doi: 10.1038/ng.2653.
- GTEx Consortium Human genomics. the Genotype-Tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648–660. doi: 10.1126/science.1262110.
- Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Translational Research. 2011;157:253–264. doi: 10.1016/j.trsl.2011.01.009.
- Gupta V, Galante A, Soteropoulos P, Guo S, Wagner BJ. Global gene profiling reveals novel glucocorticoid induced changes in gene expression of human Lens epithelial cells. Molecular Vision. 2005;11:1018–1040.
- Ha D, Dai A, Lee QV. Hyper networks. arXiv. 2020
- Hackett RA, Steptoe A, Kumari M. Association of diurnal patterns in salivary cortisol with type 2 diabetes in the whitehall II study. The Journal of Clinical Endocrinology & Metabolism. 2014;99:4625–4631. doi: 10.1210/jc.2014-2459.
- Hess AL, Larsen LH, Udesen PB, Sanz Y, Larsen TM, Dalgaard LT. Levels of circulating miR-122 are associated with weight loss and metabolic syndrome. Obesity. 2020;28:493–501. doi: 10.1002/oby.22704.
- Huang S, Chaudhary K, Garmire LX. More is better: recent progress in Multi-Omics data integration methods. Frontiers in Genetics. 2017;8:84. doi: 10.3389/fgene.2017.00084.
- Ideker T, Dutkowski J, Hood L. Boosting signal-to-noise in complex biology: prior knowledge is power. Cell. 2011;144:860–863. doi: 10.1016/j.cell.2011.03.007.
- Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–264. doi: 10.1093/biostatistics/4.2.249.
- Jewell CM, Scoltock AB, Hamel BL, Yudt MR, Cidlowski JA. Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells. Molecular Endocrinology. 2012;26:244–256. doi: 10.1210/me.2011-1116.
- Jiya A, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, Marklund SL, Moritz T. Extraction and GC/MS analysis of the human blood plasma metabolome. Analytical Chemistry. 2005;77:8086–8094. doi: 10.1021/ac051211v.
- Johannsson G, Falorni A, Skrtic S, Lennernäs H, Quinkler M, Monson JP, Stewart PM. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy. Clinical Endocrinology. 2015;82:2–11. doi: 10.1111/cen.12603.
- Johnson J. Hypernetworks in the Science of Complex Systems. Imperial College Press; 2011.
- Jonsson P, Johansson AI, Gullberg J, Trygg J, Jiya A, Grung B, Marklund S, Sjöström M, Antti H, Moritz T. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Analytical Chemistry. 2005;77:5635–5642. doi: 10.1021/ac050601e.
- Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nature Reviews Genetics. 2018;19:299–310. doi: 10.1038/nrg.2018.4.
- Karnovsky A, Weymouth T, Hull T, Tarcea VG, Scardoni G, Laudanna C, Sartor MA, Stringer KA, Jagadish HV, Burant C, Athey B, Omenn GS. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics. 2012;28:373–380. doi: 10.1093/bioinformatics/btr661.
- Karssen AM, Meijer OC, van der Sandt IC, Lucassen PJ, de Lange EC, de Boer AG, de Kloet ER. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology. 2001;142:2686–2694. doi: 10.1210/endo.142.6.8213.
- Kassambara A. ggpubr:‘ggplot2’based publication ready plots (R Package Version 0.4. 0)[Computer software] 2020
- Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. The Journal of Clinical Endocrinology and Metabolism. 1993;76:1505–1510. doi: 10.1210/jcem.76.6.8501158.
- Kovács IA, Palotai R, Szalay MS, Csermely P. Community landscapes: an integrative approach to determine overlapping network module hierarchy, identify key nodes and predict network dynamics. PLOS ONE. 2010;5:e12528. doi: 10.1371/journal.pone.0012528.
- Krämer A, Green J, Pollard J, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523–530. doi: 10.1093/bioinformatics/btt703.
- Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) Methods. 2010;50:298–301. doi: 10.1016/j.ymeth.2010.01.032.
- Kursa MB. Robustness of random Forest-based gene selection methods. BMC Bioinformatics. 2014;15:8. doi: 10.1186/1471-2105-15-8.
- Kursa MB, Rudnicki WR. Feature selection with the boruta package. Journal of Statistical Software. 2010;36:1–13. doi: 10.18637/jss.v036.i11.
- Li ZY, Xi Y, Zhu WN, Zeng C, Zhang ZQ, Guo ZC, Hao DL, Liu G, Feng L, Chen HZ, Chen F, Lv X, Liu DP, Liang CC. Positive regulation of hepatic miR-122 expression by HNF4a. Journal of Hepatology. 2011;55:602–611. doi: 10.1016/j.jhep.2010.12.023.
- Ling H, Guo Z, Du S, Liao Y, Li Y, Ding C, Song C. Serum exosomal miR-122-5p is a new biomarker for both acute coronary syndrome and underlying coronary artery stenosis. Biomarkers. 2020;25:539–547. doi: 10.1080/1354750X.2020.1803963.
- Løvås K, Husebye ES. Continuous subcutaneous hydrocortisone infusion in Addison's disease. European Journal of Endocrinology. 2007;157:109–112. doi: 10.1530/EJE-07-0052.
- Lu NZ, Collins JB, Grissom SF, Cidlowski JA. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Molecular and Cellular Biology. 2007;27:7143–7160. doi: 10.1128/MCB.00253-07.
- Malani D, Murumägi A, Yadav B, Kontro M, Eldfors S, Kumar A, Karjalainen R, Majumder MM, Ojamies P, Pemovska T, Wennerberg K, Heckman C, Porkka K, Wolf M, Aittokallio T, Kallioniemi O. Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML. Leukemia. 2017;31:1187–1195. doi: 10.1038/leu.2016.314.
- Misra BB, Langefeld CD, Olivier M, Cox LA. Integrated omics: tools, advances and future approaches. Journal of Molecular Endocrinology. 2018;1:JME-18-0055. doi: 10.1530/JME-18-0055.
- Murdoch DJ, Chow ED. A graphical display of large correlation matrices. The American Statistician. 1996;50:178–180. doi: 10.2307/2684435.
- Oldham MC, Horvath S, Geschwind DH. Conservation and evolution of gene coexpression networks in human and chimpanzee brains. PNAS. 2006;103:17973–17978. doi: 10.1073/pnas.0605938103.
- Oster H, Challet E, Ott V, Arvat E, de Kloet ER, Dijk DJ, Lightman S, Vgontzas A, Van Cauter E. The functional and clinical significance of the 24-Hour rhythm of circulating glucocorticoids. Endocrine Reviews. 2017;38:3–45. doi: 10.1210/er.2015-1080.
- Pearcy N, Chuzhanova N, Crofts JJ. Complexity and robustness in Hypernetwork models of metabolism. Journal of Theoretical Biology. 2016;406:99–104. doi: 10.1016/j.jtbi.2016.06.032.
- R Development Core Team The R project for statistical computing. [January 30, 2020];2020
- Ragnarsson O, Olsson DS, Papakokkinou E, Chantzichristos D, Dahlqvist P, Segerstedt E, Olsson T, Petersson M, Berinder K, Bensing S, Höybye C, Edén-Engström B, Burman P, Bonelli L, Follin C, Petranek D, Erfurth EM, Wahlberg J, Ekman B, Åkerman AK, Schwarcz E, Bryngelsson IL, Johannsson G. Overall and Disease-Specific mortality in patients with cushing disease: a swedish nationwide study. The Journal of Clinical Endocrinology & Metabolism. 2019;104:2375–2384. doi: 10.1210/jc.2018-02524.
- Raitoharju E, Seppälä I, Lyytikäinen LP, Viikari J, Ala-Korpela M, Soininen P, Kangas AJ, Waldenberger M, Klopp N, Illig T, Leiviskä J, Loo BM, Oksala N, Kähönen M, Hutri-Kähönen N, Laaksonen R, Raitakari O, Lehtimäki T. Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The young finns study. Scientific Reports. 2016;6:38262. doi: 10.1038/srep38262.
- Rohart F, Gautier B, Singh A, Lê Cao KA. mixOmics: an R package for 'omics feature selection and multiple data integration. PLOS Computational Biology. 2017;13:e1005752. doi: 10.1371/journal.pcbi.1005752.
- Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, Kirkup VM, Wong MC, Maddren M, Fang R, Heitner SG, Lee BT, Barber GP, Harte RA, Diekhans M, Long JC, Wilder SP, Zweig AS, Karolchik D, Kuhn RM, Haussler D, Kent WJ. ENCODE data in the UCSC genome browser: year 5 update. Nucleic Acids Research. 2013;41:D56–D63. doi: 10.1093/nar/gks1172.
- Sævik ÅB, Åkerman A-K, Methlie P, Quinkler M, Jørgensen AP, Höybye C, Debowska AJ, Nedrebø BG, Dahle AL, Carlsen S, Tomkowicz A, Sollid ST, Nermoen I, Grønning K, Dahlqvist P, Grimnes G, Skov J, Finnes T, Valland SF, Wahlberg J, Holte SE, Simunkova K, Kämpe O, Husebye ES, Bensing S, Øksnes M. Residual corticosteroid production in autoimmune addison disease. The Journal of Clinical Endocrinology and Metabolism. 2020;105:2430–2441. doi: 10.1210/clinem/dgaa256.
- Schauer N, Steinhauser D, Strelkov S, Schomburg D, Allison G, Moritz T, Lundgren K, Roessner-Tunali U, Forbes MG, Willmitzer L, Fernie AR, Kopka J. GC-MS libraries for the rapid identification of metabolites in complex biological samples. FEBS Letters. 2005;579:1332–1337. doi: 10.1016/j.febslet.2005.01.029.
- Singh S, de Ronde MWJ, Kok MGM, Beijk MA, De Winter RJ, van der Wal AC, Sondermeijer BM, Meijers JCM, Creemers EE, Pinto-Sietsma SJ. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability. Open Heart. 2020;7:e001223. doi: 10.1136/openhrt-2019-001223.
- Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. 2017;76:960–977. doi: 10.1136/annrheumdis-2016-210715.
- Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27:431–432. doi: 10.1093/bioinformatics/btq675.
- Sorgdrager FJH, Werumeus Buning J, Bos EH, Van Beek AP, Kema IP. Hydrocortisone affects fatigue and physical functioning through metabolism of tryptophan: a randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism. 2018;103:3411–3419. doi: 10.1210/jc.2018-00582.
- Stevens A, De Leonibus C, Hanson D, Dowsey AW, Whatmore A, Meyer S, Donn RP, Chatelain P, Banerjee I, Cosgrove KE, Clayton PE, Dunne MJ. Network analysis: a new approach to study endocrine disorders. Journal of Molecular Endocrinology. 2014;52:R79–R93. doi: 10.1530/JME-13-0112.
- Stimson RH, Mohd-Shukri NA, Bolton JL, Andrew R, Reynolds RM, Walker BR. The postprandial rise in plasma cortisol in men is mediated by macronutrient-specific stimulation of adrenal and extra-adrenal cortisol production. The Journal of Clinical Endocrinology & Metabolism. 2014;99:160–168. doi: 10.1210/jc.2013-2307.
- Stimson RH, Anderson AJ, Ramage LE, Macfarlane DP, de Beaux AC, Mole DJ, Andrew R, Walker BR. Acute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not direct. Diabetes, Obesity and Metabolism. 2017;19:883–891. doi: 10.1111/dom.12899.
- Stojadinovic O, Lee B, Vouthounis C, Vukelic S, Pastar I, Blumenberg M, Brem H, Tomic-Canic M. Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma Pathway, and wound healing along with promotion of terminal differentiation. The Journal of Biological Chemistry. 2007;282:4021–4034. doi: 10.1074/jbc.M606262200.
- Szalay-Beko M, Palotai R, Szappanos B, Kovács IA, Papp B, Csermely P. ModuLand plug-in for cytoscape: determination of hierarchical layers of overlapping network modules and community centrality. Bioinformatics. 2012;28:2202–2204. doi: 10.1093/bioinformatics/bts352.
- Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M, Huang HD, Tsou AP. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009;49:1571–1582. doi: 10.1002/hep.22806.
- Vlachos IS, Paraskevopoulou MD, Karagkouni D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL, Maniou S, Karathanou K, Kalfakakou D, Fevgas A, Dalamagas T, Hatzigeorgiou AG. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Research. 2015;43:D153–D159. doi: 10.1093/nar/gku1215.
- Walker BR. Glucocorticoids and cardiovascular disease. European Journal of Endocrinology. 2007;157:545–559. doi: 10.1530/EJE-07-0455.
- Wang B, Mezlini AM, Demir F, Fiume M, Tu Z, Brudno M, Haibe-Kains B, Goldenberg A. Similarity network fusion for aggregating data types on a genomic scale. Nature Methods. 2014;11:333–337. doi: 10.1038/nmeth.2810.
- Wang Y, Chang W, Zhang Y, Zhang L, Ding H, Qi H, Xue S, Yu H, Hu L, Liu D, Zhu W, Wang Y, Li P. Circulating miR-22-5p and miR-122-5p are promising novel biomarkers for diagnosis of acute myocardial infarction. Journal of Cellular Physiology. 2019;234:4778–4786. doi: 10.1002/jcp.27274.
- Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A, Lumley T, Maechler M, Magnusson A, Moeller S, Schwartz, B M. Venables gplots: Various R Programming Tools for Plotting Data. 2020
- Wickham H. Reshaping data with the reshape package. Journal of Statistical Software. 2007;21:1–20. doi: 10.18637/jss.v021.i12.
- Wickham H. New York: Springer-Verlag; 2016.
- Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Research. 2009;37:D105–D110. doi: 10.1093/nar/gkn851.
- Xu H, He JH, Xiao ZD, Zhang QQ, Chen YQ, Zhou H, Qu LH. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology. 2010;52:1431–1442. doi: 10.1002/hep.23818.
- Žitnik M, Janjić V, Larminie C, Zupan B, Pržulj N. Discovering disease-disease associations by fusing systems-level molecular data. Scientific Reports. 2013;3:3202. doi: 10.1038/srep03202.
Source: PubMed